Further reading

• Author: European Monitoring Centre for Drugs and Drug Addiction (EU body or agency)
• Pages: 45-45

TECHNICAL REPORT | Balancing access to opioid substitution treatment with preventing diversion of medications

45

WHO (2011), Ensuring balance in nati onal policies on controlled substa nces: guidance for availability and

accessibility of controlled medicines, WHO, Geneva.

Winstock, A. R., Lea, T. and Jackson, A. P. (2009a), ‘Methods and motivations for buprenorphine

diversion from public opioid substitu tion treatment clinics’, Journal of Addictiv e Diseases 28, pp.

57-63.

Winstock, A. R., Lea, T. and Sheridan, J. (2009b), ‘What is diversion of s upervised buprenorphine and

how common is it?’, Journal of Addictiv e Diseases 28, pp. 269-278.

Worley, J. and Thomas, S. P. (2014), ‘Women who d octor shop for prescription drugs’, Western Journal

of Nursing Research 36, pp. 456-474.

Wright, C. (1992), Medical Officer Briefing Pac kage: The Houston Methadone Ou tbreak, Food and Drug

Administration, Rockville.

Wright, N., D’Agnone, O., Krajci, P., Littlewood, R., Alho, H., Reimer, J., Roncero, C., Soma ini, L. and

Maremmani, I. (2016), ‘Addressing mis use and diversion of opioid substitut ion medication:

guidance based on systematic evidence r eview and real-world experience’, Jo urnal of Public

Health 38(3), pp. e368-e374.

Yokell, M., Zaller, N., Green, T. and R ich, J. (2011), ‘Buprenorphine and bu prenorphine/naloxone

diversion, misuse, and Illicit use: an inter national review’, Current Drug Abus e Reviews 4(1), pp.

28-41.

Further reading

Darke, S., Topp, L. and Ross, J. (2002) , ‘The injection of methadone and benz odiazepines among

Sydney injecting drug users 1996-2000 : 5-year monitoring of trends from the il licit drug reporting

system’, Drug and Alcohol Review 21(1), pp. 27-32.

Kelleher, C. (2018), ‘Characteristics of methadone-related overdose deaths an d comparisons between

those dying on and off opioid agonist treatment’, Drugnet Ireland 64.

Launonen, E., Alho, H., Kotovirta, E., Wallace, I. and Simojoki, K. (2015), ‘Diversion of opioid

maintenance treatment medications and predictors for diversion among Fi nnish maintenance

treatment patients’, International Jour nal of Drug Policy 26(9), pp. 875-882.

Winstock, A., Lea, T. and Sheridan, J. (2008), ‘Prevalence of diversion and injection of methadone and

buprenorphine among clients receivin g opioid treatment at community phar macies in New South

Wales, Australia’, International Journa l of Drug Policy 19(6), pp. 450-458.